Asset
Adapalene
Bausch Health Companies Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (3)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT00714714 | phase4 | completed | 2008-01-01 | 2008-02-01 | Bausch Health Americas, Inc. | Evaluation of Irritation That Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face. |
| NCT00952523 | phase4 | completed | 2009-07-01 | 2009-10-01 | Bausch Health Americas, Inc. | Evaluation of Irritation That Potentially Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face |
| NCT00919191 | phase4 | completed | 2009-04-01 | 2009-05-01 | Bausch Health Americas, Inc. | Evaluation of Irritation by Two Facial Gels Applied to Opposite Sides of the Face |
FDA applications (1)
| Application | Type | Applicant |
|---|---|---|
| NDA 216632 | NDA | BAUSCH HEALTH US LLC |
Marketed products (1)
- CABTREO